Whole Genome Sequencing for Korean Diffuse Gastric Cancer
Fastq files for the whole genome sequencing data (Illumina HiSeq 2500; 32.6-fold) for two diffuse gastric cancers revealing the fusion breakpoints. 2102T: CTNND1-ARHGAP26 gene fusion (g.chr11:57,578,103-g.chr5:142,358,707) 354T: ANXA2-MYO9A gene fusion (g.chr15:60,656,550-g.chr15:72,157,966)
- 2 samples
- DAC: EGAC00001000439
- Technology: Illumina HiSeq 2500
Korean Diffuse Gastric cancer
Jan 9, 2104European Genome-phenome ArchiveEuropean Bioinformatics InstituteEuropean Molecular Biology LaboratoryWellcome Trust Genome CampusHinxton, Cambridge, CB10 1SDUnited KingdomDAC NAME AND ACCESSIONThis document specifies the policy for granting access to the European Genome-phenome Archive (EGA) secure Web based tools for managing data access permissions to the data stored in the EGA database. Access is granted to those Data Access Committee members named in this document by Paul Flicek, head of Genes, Genomes and Variation.Conditions of access:The account holder will abide by all current and future policies of the EBI for computer use as well as computer use policies of the European Molecular Biology Laboratory (EMBL), of which the EBI is a part. All EGA specific policies and standard operating procedures (SOPs) must also be followed. All applicable policies will be provided to the authorized users. Method of access:The EBI will create a personal account for the authorized person. The account username and password together with a RSA key provide access to the secure EGA infrastructure. A separate document with detailed guidelines on how to access and use these tools is provided to each account holder. The EGA help-desk provides training when needed.Review:All individuals will access to the EGA user authorization tools will be reviewed annually by Paul Flicek. Any staff changes affecting the authorized person must be provided immediately to Paul Flicek (flicek@ebi.ac.uk).Authorized Data Access Committee user:<Full name>Hark K. Kim<Postal address for RSA Key>National Cancer Center, 323 Ilsanro, Goyang, Gyeonggi, 410-769, Republic of Korea<Email>hkim@ncc.re.krSignature of authorized user indicating that this policy has been read and understood.Supervisor of Authorized user:<Full name> Hark K. Kim<Title>Chief, Biomolecular Function Research Branch<Email>hkim@ncc.re.krSignature supervisor of authorized user indicating that this policy has been read and understood
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001001711 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
ID | File Type | Size | Located in | |
---|---|---|---|---|
EGAF00001848242 | fq.gz | 29.8 GB | ||
EGAF00001848243 | fq.gz | 34.2 GB | ||
EGAF00001848244 | fq.gz | 26.4 GB | ||
EGAF00001848245 | fq.gz | 29.1 GB | ||
4 Files (119.5 GB) |